0QF:ETR
Moderna Inc
172,14 €
arrow_downward
−1,87%(−3,28) 1 p
30. sept, 11:11:59 GMT +2 · EUR
search
Kõik sümbolid
1 p
5 p
1 kuu
6 kuud
YTD
1 a
5 a
MAX
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse 0QF põhistatistika genereerimine…
Ava
180,86 €
Kõrge
182,00 €
Madal
172,14 €
Turu kapit.
81,23 mld
Keskm. maht
44,42 tuh
Maht
9,46 tuh
52 näd kõrgeim
184,20 €
52 näd madalaim
19,37 €
Töötajate arv
5 tuh
Ava
180,86 €
Kõrge
182,00 €
Madal
172,14 €
Turu kapit.
81,23 mld
Keskm. maht
44,42 tuh
Maht
9,46 tuh
52 näd kõrgeim
184,20 €
52 näd madalaim
19,37 €
Töötajate arv
5 tuh
Uudised
Veebiallikatest ja uudistepartneritelt
AD HOC NEWS
·
2 tunni eest
Moderna stock pre-market at EUR 181.09: plus 1.46 percent
Investing.com Nigeria
·
19 tunni eest
Moderna stock hits 52-week high at 202.69 USD By Investing.com
The Globe and Mail
·
1 päeva eest
Moderna vs. BioNTech: Which mRNA Cancer Stock Has More Upside?
Yahoo Finance
·
1 päeva eest
Up Over 550% in 2026, Is It Too Late to Buy Moderna Stock?
Profiil
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In 2026, Time ranked Moderna as number one in their World's Most Impactful Companies list. Wikipedia
Teave üksuse Moderna Inc kohta